TAP and IMS for HIPEC

计划入组 81 人 · 首次发布于 2021 年 7 月 29 日

IMS-treatment and Canalis Carpi Syndrome

计划入组 75 人 · 首次发布于 2010 年 4 月 13 日

Interventional Management of Stroke (IMS) II Study

计划入组 81 人 · 首次发布于 2005 年 10 月 25 日

IMS-001

IMS-088

INO-2002

IMS & SUM HOSPITAL

India

IMS TOKYO KATSUSHIKA GENERAL HOSPITAL

Japan

INSTITUTO DE POS GRADUACAO EM CIENCIAS DA SAUDE IZAMAR MILIDIU DA SILVA

Brazil

FDA Approves Sandoz's Erelzi as First Enbrel Biosimilar in US

Four Key Drivers Reshaping Successful Oncology Drug Launches in Modern Market

Sandoz Marks Biosimilars Milestone with $1B Sales, Plans Five Major Launches by 2020